These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 889677)
1. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Stanley JA; Shipley WU; Steel GG Br J Cancer; 1977 Jul; 36(1):105-13. PubMed ID: 889677 [TBL] [Abstract][Full Text] [Related]
2. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo. Stephens TC; Adams K; Peacock JH Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945 [TBL] [Abstract][Full Text] [Related]
3. Lewis lung carcinoma in mice as an experimental therapy model. II. The effect of BCNU, cyclophosphamide and/or surgery treatment on early and advanced tumor in mice. BudzyĆski W Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):373-7. PubMed ID: 7184488 [TBL] [Abstract][Full Text] [Related]
4. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Hill RP; Stanley JA Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304 [TBL] [Abstract][Full Text] [Related]
5. Size dependence of the response of Lewis lung tumors to BCNU. Steel GG; Adams K; Stanley J Cancer Treat Rep; 1976 Dec; 60(12):1743-8. PubMed ID: 1026332 [TBL] [Abstract][Full Text] [Related]
6. The proliferative state of clonogenic cells in the Lewis lung tumour after treatment with cytotoxic agents. Bateman AE; Steel GG Cell Tissue Kinet; 1978 Sep; 11(5):445-54. PubMed ID: 569015 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity of normal mouse marrow and RIF-1 tumour to hyperthermia combined with cyclophosphamide or BCNU: a lack of therapeutic gain. Honess DJ; Bleehen NM Br J Cancer; 1982 Aug; 46(2):236-48. PubMed ID: 6758828 [TBL] [Abstract][Full Text] [Related]
8. Influence of tumour size on radiosensitization by misonidazole. Stanley JA; Peckham MJ; Steel GG Br J Cancer Suppl; 1978 Jun; 3():220-4. PubMed ID: 277232 [TBL] [Abstract][Full Text] [Related]
9. Tumor size dependency in the radiation response of the Lewis lung carcinoma. Shipley WU; Stanley JA; Steel GG Cancer Res; 1975 Sep; 35(9):2488-93. PubMed ID: 1149047 [TBL] [Abstract][Full Text] [Related]
10. Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours. Rofstad EK; Sutherland RM Br J Cancer; 1989 Jan; 59(1):28-35. PubMed ID: 2757922 [TBL] [Abstract][Full Text] [Related]
11. Is cell survival a determinant of the in situ response of 9L tumours? Wheeler KT; Wallen CA Br J Cancer Suppl; 1980 Apr; 4():299-303. PubMed ID: 6932940 [TBL] [Abstract][Full Text] [Related]
12. Temporal interactions in the Lewis lung tumour between cytotoxic drugs and acute or fractionated radiotherapy. Stephens TC; Adams K; Peacock JH; Steel GG Radiother Oncol; 1986 Feb; 5(2):137-46. PubMed ID: 3704188 [TBL] [Abstract][Full Text] [Related]
13. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour. Twentyman PR; Bleehen NM Br J Cancer; 1976 Mar; 33(3):320-8. PubMed ID: 57788 [TBL] [Abstract][Full Text] [Related]
14. Enhanced tumor cell radiosensitivity in artificial pulmonary metastases of the Lewis lung carcinoma. Shipley WU; Stanley JA; Steel GG Int J Radiat Oncol Biol Phys; 1976; 1(3-4):261-6. PubMed ID: 972087 [No Abstract] [Full Text] [Related]
15. Identification of a subpopulation of MeCCNU resistant cells in previously untreated Lewis lung tumours. Stephens TC; Adams K; Peacock JH Br J Cancer; 1984 Jul; 50(1):77-83. PubMed ID: 6743517 [TBL] [Abstract][Full Text] [Related]
16. A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy. Thomas JM Br J Surg; 1979 Oct; 66(10):696-700. PubMed ID: 509043 [TBL] [Abstract][Full Text] [Related]
17. Reducing intratumour acute hypoxia through bevacizumab treatment, referring to the response of quiescent tumour cells and metastatic potential. Masunaga S; Liu Y; Tanaka H; Sakurai Y; Suzuki M; Kondo N; Maruhashi A; Ono K Br J Radiol; 2011 Dec; 84(1008):1131-8. PubMed ID: 21586505 [TBL] [Abstract][Full Text] [Related]
18. Correlation between tumour size, metastatic spread and galactosyl transferase activity in cyclophosphamide-treated mice bearing the Lewis lung carcinoma. Capel ID; Jenner M; Pinnock MH; Dorrell HM; Payne DC; Williams DC Oncology; 1979; 36(5):242-4. PubMed ID: 481846 [TBL] [Abstract][Full Text] [Related]
19. Changes in pH and blood flow induced by glucose, and their effects on hyperthermia with or without BCNU in RIF-1 tumours. Hiraoka M; Hahn GM Int J Hyperthermia; 1990; 6(1):97-103. PubMed ID: 2299240 [TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas. Blackett NM; Courtenay VD; Mayer SM Cancer Chemother Rep; 1975; 59(5):929-33. PubMed ID: 1203897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]